NECTIN4 and urinary bladder cancer: As data on NECTIN4 expression in normal urothelium are scarce, further studies should investigate NECTIN4 levels in normal urothelium of bladder cancer patients as possibly relevant regarding potential side effects of enfortumab vedotin treatment.